The visual takeaway is that KLOWs protocol is a fading frequency pattern laid over a flat dose line
During IV NAD+ infusions , patients commonly report a constellation of symptoms that may include: Gastrointestinal disturbances : Nausea, abdominal cramping, and occasionally vomiting are frequently reported, particularly when infusion rates are too rapid Chest discomfort : Some patients report a sensation of heaviness or pressure in the chest area, which typically improves when the infusion is slowed Headache : Ranging from mild to moderate intensity Muscle cramping : Particularly in the legs and abdomen Anxiety or restlessness : Some individuals report feeling jittery during infusion Infusion site reactions : Pain, redness, or swelling at the injection site Potential infection risk : As with any IV therapy, there is a risk of infection or thrombophlebitis The mechanism underlying these side effects is not fully understood but may relate to changes in cellular metabolic activity

Manufacturers of generic versions of weight-loss drugs are eyeing a market that, according to estimates from banks such as BTG Pactual and Santander, was worth between BRL 6 billion (USD 1.1 billion) and BRL 10 billion (USD 1.9 billion) in Brazil in 2025
Types of vesicles used such as MLV, SUV or large unilamellar vesicles (LUV) and their encapsulation efficiency varies greatly from 1% for SUVs to 88% for MLVs
Interestingly, the elevated blood homocysteine concentrations associated with riboflavin deficiency rapidly decline during alcohol withdrawal (30)
00:06:39 Sara Klockars: Right, right